Form 8-K - Current report:
SEC Accession No. 0001193125-25-009173
Filing Date
2025-01-21
Accepted
2025-01-21 08:51:56
Documents
14
Period of Report
2025-01-20
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d901098d8k.htm   iXBRL 8-K 20888
2 EX-10.1 d901098dex101.htm EX-10.1 54289
  Complete submission text file 0001193125-25-009173.txt   193397

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA ck0001314966-20250120.xsd EX-101.SCH 2539
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE ck0001314966-20250120_lab.xml EX-101.LAB 14400
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ck0001314966-20250120_pre.xml EX-101.PRE 9076
17 EXTRACTED XBRL INSTANCE DOCUMENT d901098d8k_htm.xml XML 3083
Mailing Address 100 BELLEVUE PARKWAY WILMINGTON DE 19809
Business Address 100 BELLEVUE PARKWAY WILMINGTON DE 19809 (888) 825-2257
BlackRock Health Sciences Trust (Filer) CIK: 0001314966 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE
Type: 8-K | Act: 34 | File No.: 811-21702 | Film No.: 25540633